Ms. Michelle Lefler reports

AURORA UNVEILS PREMIUM RESIN CARTRIDGES IN AUSTRALIA

Aurora Cannabis Inc., in conjunction with MedReleaf Australia, has launched its premium 1.2-gram resin cartridges in Australia. This expansion marks a significant step in Aurora's mission to provide high-quality products to patients worldwide. Now available for doctors to prescribe to patients in Australia, Aurora's new resign cartridges, developed and manufactured at the company's EU-GMP (European Union good manufacturing practice) and TGA-GMP (Therapeutic Goods Administration good manufacturing practice) certified facility, will be distributed by MedReleaf Australia.

"We are thrilled to bring premium resin cartridges to the Australian market, a signal of our commitment to expanding patient access to an even greater variety of premium cannabis," said Kristin Viccars, interim managing director, MedReleaf Australia. "Our products are designed with the highest standards of quality with safety in mind, and we are confident that Australian patients will value the unique experience our cartridges offer. We continue to look at new opportunities to expand our portfolio and patient care."

The new resin cartridges include offerings from Aurora and IndiMed. The IndiMed brand offering focuses on providing affordable medicine and improving access for patients. The Aurora brand offering features cultivar-specific options such as Sourdough and Electric Honeydew, Aurora's leading proprietary cultivars. All products are full spectrum, ensuring a comprehensive cannabinoid profile for a more effective and balanced experience. These resin cartridges represent a significant advancement for MedReleaf Australia as it continues to expand its product line-up in the market. The new resign cartridges are available as of June 4, 2024.

Key features of Aurora and Indimed's resin cartridges include:

• Exceptional flavour profiles: Using high-quality terpenes and pure extracts to deliver rich and authentic flavours.
• High potency: Ensures a powerful and consistent experience with each use.
• Safety and quality: Manufactured in state-of-the-art facilities, adhering to strict TGA-GMP quality control and safety standards.
• User-friendly design: Easy to use, making it a convenient choice for all patients.

For additional information, doctors and health care professionals can contact MedReleaf Australia's clinical support team or visit its website.

About Aurora Cannabis

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

We seek Safe Harbor.